

Endo Supreme
Supreme Nutrition Products
Overview
Endo Supreme contains Suma, an herbal supplement with research suggesting potential benefits for cardiovascular health, blood sugar management, and weight management. Studies indicate improvements in lipid profiles, glycemic control, and blood pressure with consistent use over several weeks. The provided dosage of Suma is within the range that has shown some effectiveness in studies.
The Good
May improve cardiovascular health by reducing LDL cholesterol and triglycerides, and increasing HDL cholesterol.
May help manage blood sugar levels by reducing fasting blood glucose and improving insulin sensitivity.
May assist in weight management by reducing body weight and BMI.
The Bad
Potential interactions with blood thinners and diabetes medications.
Gastrointestinal discomfort may occur in some individuals.
Contraindicated during pregnancy or breastfeeding due to limited safety data.
Is it for you?
Best For: Individuals seeking endocrine or hormonal support, those with specific health goals related to the product's intended use
Skip If: You are pregnant, nursing, or have pre-existing medical conditions without consulting a healthcare professional.
Ingredients Analysis
Suma
330 mgHow to Use
Follow label directions for dosage. Typically taken with water or a meal.
Daily
Morning or Evening
With food
Who Should Use This
Best For:
Recommended Articles

Pre-Surgery Diet: What to Avoid
Certain foods, supplements, and medications should be avoided before surgery to minimize anesthesia risks and improve surgical outcomes.

Top Immune-Support Supplements for Cold Season
Vitamin C, Zinc, Echinacea, and Vitamin D are key supplements for supporting immunity during the cold season.
Weight Loss in 2025: Supplements vs. Natural Methods
In 2025, while supplements are popular, a balanced diet and exercise are more effective for sustainable weight loss.

Top GMP-Certified Collagen Brands 2025
GMP certification is essential for collagen peptide quality, with several brands leading the market by 2025.